Structural Heart Closure Devices | Market Insights | Global | 2022
The global market for structural heart closure devices will be limited by declining ASPs due to a number of factors, including cost-containment measures such as MACRA and the 2-Midnight Rule in the US, intense pricing pressures due to economic constraints in Europe, and the biennial reimbursement cuts by the Japanese MHLW. Moreover, the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020. However, the global market for structural heart closure devices will grow rapidly in most countries covered through 2030, driven by strong clinical data, the availability of reimbursement, a growing body of trained physicians, and the uptake of premium-priced technologies, especially in the PFO and LAA closure device spaces.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the global structural heart closure devices, with market projections across an 11-year period.
